Amicus Therapeutics Inc (FOLD)
9.91
+0.21
(+2.16%)
USD |
NASDAQ |
Jun 27, 16:00
9.905
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Net Income (Annual): -151.58M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -151.58M |
| December 31, 2022 | -236.57M |
| December 31, 2021 | -250.46M |
| December 31, 2020 | -276.85M |
| December 31, 2019 | -356.39M |
| December 31, 2018 | -349.00M |
| December 31, 2017 | -284.00M |
| December 31, 2016 | -200.04M |
| December 31, 2015 | -132.12M |
| December 31, 2014 | -68.93M |
| December 31, 2013 | -59.63M |
| Date | Value |
|---|---|
| December 31, 2012 | -48.78M |
| December 31, 2011 | -44.41M |
| December 31, 2010 | -54.94M |
| December 31, 2009 | -6.567M |
| December 31, 2008 | -39.36M |
| December 31, 2007 | -41.17M |
| December 31, 2006 | -46.34M |
| December 31, 2005 | -19.97M |
| December 31, 2004 | -8.807M |
| December 31, 2003 | -6.768M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-356.39M
Minimum
2019
-151.58M
Maximum
2023
-254.37M
Average
-250.46M
Median
2021
Net Income (Annual) Benchmarks
| Insmed Inc | -749.57M |
| Rhythm Pharmaceuticals Inc | -184.68M |
| Alnylam Pharmaceuticals Inc | -440.24M |
| Cytokinetics Inc | -526.24M |
| InfuSystems Holdings Inc | 0.872M |